Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis

Stroke

Volumn 40, Issue 3, 2009, Pages 719-725

  Waddy, Salina P ^a   Cotsonis, George ^b   Lynn, Michael J ^b   Frankel, Michael R ^a   Chaturvedi, Seemant ^c   Williams, Janice E ^d   Chimowitz, Marc ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Atherosclerosis; Race; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN; ANTITHROMBOCYTIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BRAIN HEMORRHAGE; CAUCASIAN; COMORBIDITY; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; STROKE; TREATMENT OUTCOME; AGED; BIOASSAY; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEMODYNAMICS; MIDDLE AGED; MULTICENTER STUDY; NEGRO; PHYSIOLOGY; RACE; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; STENOSIS, OCCLUSION AND OBSTRUCTION; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTICOAGULANTS; ASPIRIN; CANADA; CEREBRAL ANGIOGRAPHY; CONSTRICTION, PATHOLOGIC; CONTINENTAL POPULATION GROUPS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMODYNAMICS; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; WARFARIN;

EID: 62449314894     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.526624     Document Type: Article

References (25)

1. Solberg LA, McGarry PA. Cerebral atherosclerosis in negroes and Caucasians. Atherosclerosis. 1972;16:141-154.
2. Gorelick PB, Caplan LR, HierDB, Parker SL, Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology. 1984;34:54-57.
3. Gorelick PB, Caplan LR, Hier DB, Patel D, Langenberg P, Pessin MS, Biller J, Kornack D. Racial differences in the distribution of posterior circulation occlusive disease. Stroke. 1985;16:785-790.
4. Sacco RL, Kargman DE, Gu Q, Zammanillo MC. Race-ethnicity and determinates of intracranial atherosclerotic cerebral infraction: The Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
5. Inzitari D, Hachinski VC, Wayne Taylor D, Barnett HJM. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factors? Arch Neurol. 1990;47:1080-1084.
6. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
7. The Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22:106-117.
8. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial stenosis. AJNR Am J Neuroradiol. 2000;21:643-646.
9. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Inlern Med. 1997;157:2413-2446.
10. American Diabetes Association: Clinical Practice Recommendations 1999: Position Statement. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care. 1999;22(1S):32S-41S.
11. Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Third Report of National Cholesterol Education Program Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486-2497.
12. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stem BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
13. Cooper R, Sempos C, Hsieh SC, Kovar MG. Slowdown in decline of stroke mortality in the United States, 1978-1986. Stroke. 1990;21: 1274-1279.
14. Stansbury J, Jia H, Williams L, Vogel W, Duncan P. Ethnic disparities in stroke epidemiology, acute care, and postacute outcomes. Stroke. 2005; 36:374-387.
15. Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K, Moomaw CJ, Schneider A, Miller R, Shukla R, Kissela B. The unchanging incidence and case-fatality of stroke in the 1990s: population-based study. Stroke. 2006;37:2473-2478.
16. Sacco R, Hauser W, Mohr JP, Foulkes M. One-year outcome after cerebral infarction in whites, blacks, and hispanics. Stroke. 1991;22: 305-311.
17. Sacco R, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S. Race-ethnic disparities in impact of stroke risk factors: Northern Manhattan Stroke Study. Stroke. 2001;32:1725-1731.
18. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD; for the South London Stroke Register. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in South London Stroke Register. Stroke. 2003;34:1457-1463.
19. Kannel WB, McGee DL. Diabetes and cardiovascular disease: Framingham study. JAMA. 1979;241:2035-2038.
20. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147.
21. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;6:434-444.
22. Chaturvedi S, Turan T, Lynn M, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI; WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068.
23. Kapral M, Wang H, Mamdani M, Tu J. Effect of socioeconomic status on treatment and mortality after stroke. Stroke. 2002;33:268-275.
24. Jakovljevic D, Sarti C, Sivenius J, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Alhainen K, Kuulasmaa K, Tuomilehto J, Puska P, Salomaa V. Socioeconomic status and ischemic stroke. Stroke. 2001;32:1492-1498.
25. Barnett H, Taylor W, Eliasziw M, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415-1425.